Filed by newsfilecorp.com NEWS RELEASE Lexaria Products SOLD OUT in Vegas; Coffee and Cocoa Introduction. Kelowna, BC

Lexaria Products SOLD OUT in Vegas;

Coffee and Cocoa Introduction.

Kelowna, BC November 17, 2015 - Lexaria Corp.

(LXRP-OTCQB) (LXX-CSE) (the "Company" or "Lexaria") announces an

overwhelmingly positive response to the new Lexaria Energy Protein Bar at its

unveiling at three investment and business trade show conferences in Las Vegas,

November 9 through November 13.

All of the hundreds of Lexaria protein bars brought to Las

Vegas SOLD OUT due to overwhelming demand for this unique new product by

discerning consumers searching for healthy and convenient ways to experience the

superfood qualities of hemp oil edibles. In addition nearly 1,000 servings of

ViPovaTM teas were also sold, selling out all available conference

Attendees at the conferences also enjoyed an unexpected

development: Lexaria introduced limited quantities of its hemp oil infused

coffee and cocoa in advance of a broader rollout and e-commerce sales which will

begin within two weeks or less. All the new products coffee, cocoa and protein

bars will join the existing ViPovaTM Tea family in special holiday

marketing in time for the busy Thanksgiving and Christmas seasons.

Roughly 1,000 people taste-tested the Cashew Berry and

Chocolate Berry protein bars to nearly unanimous acclaim. People who have

previously experienced hemp oil or CBD oil infused products were universally

surprised at the excellent taste and texture experience offered by the Lexaria

All our food products taste great, says John Docherty,

President of Lexaria. The protein bars in particular are demonstrating that our

technology really works to deliver a superior taste profile to consumers who no

longer have to choose between great taste and great nutrition for hemp oil

infused products. Lexaria also discussed product distribution possibilities

with many licensed cannabis dispensaries with one of the most prestigious

dispensaries in Nevada to begin selling ViPovaTM and Lexaria products

immediately. Additional select dispensary distribution in locations like

Colorado, California, Alaska and Nevada is to be arranged soon. Traditional

retailers in the Las Vegas area also expressed their interest in selling the

Lexaria Energy protein bar.

Separately, Lexaria is in the midst of its direct marketing and

sales campaign for the Lexaria protein bars to select gyms and fitness centers

in the Western US. Feedback from this initial campaign will be used to optimize

the sales campaign to best acquire long term retail points of sale. The first 250 gym and fitness locations under this

program are being contacted now and evaluated for distribution opportunities,

with this program slated for completion prior to December 15. Lexaria then

expects to roll-out its sales efforts in the New Year beginning with another

roughly 2,000 pre-selected fitness centers across the US.

Health Club and gym owners, or other retailers interested in

offering this unique product, should call (1-843-952-3764 or 1-888-976-8482) to

place initial stocking orders or visit www.lexariaenergyfoods.com. The

bars are gluten free, all-natural with no artificial ingredients, no artificial

flavors, no preservatives, no corn syrup, and no added sugars (other than

sweetened blueberries).

Lexaria is a food sciences company, with common shares quoted

in the USA with symbol LXRP and in Canada with symbol LXX. The company searches

for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit

www.lexariaenergy.com.

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements

which are not historical facts are forward-looking statements. The Company makes

forward-looking public statements concerning its expected future financial

position, results of operations, cash flows, financing plans, business strategy,

products and services, competitive positions, growth opportunities, plans and

objectives of management for future operations, including statements that

include words such as "anticipate," "if," "believe," "plan," "estimate,"

"expect," "intend," "may," "could," "should," "will," and other similar

expressions are forward-looking statements, including but not limited to:

achieving potential sales through distribution at either licensed dispensaries

or at traditional retailers. Such forward-looking statements are estimates

reflecting the Company's best judgment based upon current information and

involve a number of risks and uncertainties, and there can be no assurance that

other factors will not affect the accuracy of such forward-looking statements.

Access to capital, or lack thereof, is a major risk and there is no assurance

that the Company will be able to raise required working capital. Factors which

could cause actual results to differ materially from those estimated by the

Company include, but are not limited to, government regulation, managing and

maintaining growth, the effect of adverse publicity, litigation, competition,

the patent application and approval process and other factors which may be

identified from time to time in the Company's public announcements and filings.

There is no assurance that the medical marijuana, hemp oil sector, or

alternative health businesses will provide any benefit to Lexaria, or that the

Company will experience any growth through participation in these sectors. There

is no assurance that existing capital is sufficient for the Company's needs or

that it will not need to attempt to raise additional capital. There is no

assurance that any planned corporate activity, business venture, or initiative

will be pursued, or if pursued, will be successful. There is no assurance that

any hemp oil or cannabinoid-based product will promote, assist, or maintain any

beneficial human health conditions whatsoever. There is no assurance that the

cannabinoid/lipid infusion technology will provide any increase in

bioavailability to any individual person. There is no assurance that any patent

application in the USA or any other nation or under any treaty will result in

the award of an actual patent; nor that an award of any actual patent will

protect against challenges from unknown third parties. There is no assurance

that any of Lexaria s postulated uses, benefits, or advantages for the

patent-pending technology will in fact be realized in any manner or in any part.

No statement herein has been evaluated by the Food and Drug Administration

(FDA). ViPovaTM products and Lexaria Energy products are not intended

to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility

for the adequacy or accuracy of this release.